logo

Rain Therapeutics Inc. (RAIN)



Trade RAIN now with
  Date
  Headline
11/19/2021 8:17:18 AM Rain Therapeutics Doses First Patient In Phase 2 Basket Trial Of Milademetan For MDM2-Amplified Advanced Solid Tumors